Teniposide as single drug therapy for elderly patients affected by small cell lung cancer
- 31 May 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (6) , 1081-1084
- https://doi.org/10.1016/0959-8049(92)90462-b
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Treatment of small cell lung cancer (SCLC) in the elderly: F.A. Shepherd, W.K. Evans, P.E. Goss, University of Toronto, Toronto, CanadaLung Cancer, 1991
- Cancer in the elderly: why so badly treated?The Lancet, 1990
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989
- Small cell lung cancer in the elderly. Factors influencing the results of chemotherapy: a reviewLung Cancer, 1989
- A phase II study of oral etoposide in elderly patients with small cell lung cancer.Thorax, 1989
- Aging and cancer.Journal of Clinical Oncology, 1988
- Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)European Journal of Cancer and Clinical Oncology, 1988
- Chemotherapy in the elderlyEuropean Journal of Cancer and Clinical Oncology, 1987
- Cancer Incidence and Survival in Patients 65 Years of Age and OlderCA: A Cancer Journal for Clinicians, 1986
- Drug Therapy in the ElderlyAnnals of Internal Medicine, 1981